Issue of Equity and Total Voting Rights

Summary by AI ^BETAClose X

Oxford Nanopore Technologies plc announced the issuance of 266,645 ordinary shares as of March 31, 2026, due to the exercise of share options and remuneration schemes. These shares have been admitted to the FCA's Official List and the London Stock Exchange's main market. Following this issuance, the company's total issued share capital stands at 967,364,692 ordinary shares, with no shares held in treasury, resulting in a total of 967,364,692 voting rights. The company retains the capacity to admit an additional 5,160,512 ordinary shares under its existing block admission facility.

Disclaimer*

Oxford Nanopore Technologies plc

01 April 2026

Oxford Nanopore Technologies plc (the "Company")

Issue of Equity and Total Voting Rights

The Company today announces in respect of the month ended 31 March 2026, the issue of 266,645 ordinary shares of £0.0001 each ("Ordinary Shares"), following the exercise of options granted under the Company's share option plans and issuance of shares under certain of the Company's remuneration schemes.

Such Ordinary Shares were also admitted to the Official List of the Financial Conduct Authority ("FCA") and to trading on the London Stock Exchange's main market for listed securities under the Company's block admission facility. Following this issue, the Company has the ability to admit a further 5,160,512 Ordinary Shares under its October 2021 block admission facility.

In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company announces that as at 31 March 2026, the Company's issued share capital consisted of 967,364,692 Ordinary Shares. The Company did not hold any shares in treasury. Accordingly, the total number of voting rights in the Company as at 31 March 2026 is 967,364,692. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Investors

ir@nanoporetech.com

Media

media@nanoporetech.com

OxfordNanoporeTechnologies@teneo.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END